Clinical Trials Browser

Metastatic Progressive Castration-resistant Prostate Cancer × enzalutamide × Clear all

NCT01091103 2018-10-23

Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide

Phase 2 Completed

60 enrolled 20 charts

Metastatic Progressive Castration-resistant Prostate Cancer